Literature DB >> 7283746

Effects of lead, copper, and zinc on the rat's lactate dehydrogenase in vivo and in vitro.

W Dobryszycka, H Owczarek.   

Abstract

Following subacute intoxication of rats with Pb-, Cu-, and Zn-salts (separately or in mixture) for 5 weeks, the chelating agent D-penicillamine was administered for 3 weeks. In the course of the 3-month experiment, lactate dehydrogenase (LDH) was estimated in serum and in cytoplasmic fraction of the kidney. Pb2+ treatment resulted in an increase of LDH activity, Cu2+ in a slight decrease, whereas Zn2+ had no effect, respectively. Mixture of these metals caused a significant rise in the enzymatic activity. Seven weeks after the stoppage of the administration of toxic substances, altered LDH activity, both in serum and in kidney returned to normal. D-penicillamine treatment was found to accelerate a restoration of the enzyme activity. In the experiments in vitro, Cu2+ inhibited significantly the kidney LDH activity, Pb2+ and Zn2+ being 100- and 400-times less efficient, respectively. Cu2+ inhibition was reversed by D-penicillamine, whereas inhibition of LDH by Zn2+ or Pb2+ was irreversible.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283746     DOI: 10.1007/BF00297072

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Approaches to the study of enzyme mechanisms lactate dehydrogenase.

Authors:  J J. Holbrook; H Gutfreund
Journal:  FEBS Lett       Date:  1973-04-15       Impact factor: 4.124

2.  Effect of penicillamine on some metals and metalloproteins in the rat.

Authors:  V Albergoni; A Cassini; N Favero; G P Rocco
Journal:  Biochem Pharmacol       Date:  1975-05-15       Impact factor: 5.858

3.  Lactic dehydrogenase activity in human serum.

Authors:  H G WEINSTEIN; H J ZIMMERMAN
Journal:  J Lab Clin Med       Date:  1956-10

4.  Comparative effects of experimental lead poisoning on enzymatic activities of kidney and liver in rat.

Authors:  A Iannaccone; P Boscolo; G Bombardieri
Journal:  Life Sci       Date:  1976-08-01       Impact factor: 5.037

Review 5.  Biochemical effects of mercury, cadmium, and lead.

Authors:  B L Vallee; D D Ulmer
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

6.  Kinetics of lead retention and distribution in suckling and adult rats.

Authors:  B Momcilović; K Kostial
Journal:  Environ Res       Date:  1974-10       Impact factor: 6.498

7.  The effects of penicillamine on the body burdens of several heavy metals.

Authors:  A J Silva; D G Fleshman; B Shore
Journal:  Health Phys       Date:  1973-05       Impact factor: 1.316

8.  The effect of experimental lead poisoning on some enzymatic activities of the kidney.

Authors:  G C Secchi; L Alessio; A Cirla
Journal:  Clin Chim Acta       Date:  1970-03       Impact factor: 3.786

9.  [Activity of various blood serum enzymes of rats during administration of Pb, Cu, and Zn salts and D-penicillamine therapy].

Authors:  W Dobryszycka; H Owczarek; J Kulpa; K Lukasik-Lemańska
Journal:  Acta Pol Pharm       Date:  1979       Impact factor: 0.330

10.  Hepatic copper- and zinc-binding proteins in ruminants. 2. Relationship between Cu and Zn concentrations and the occurrence of a metallothionein-like fraction.

Authors:  I Bremner; R B Marshall
Journal:  Br J Nutr       Date:  1974-09       Impact factor: 3.718

View more
  3 in total

1.  Biochemical effects of copper nanomaterials in human hepatocellular carcinoma (HepG2) cells.

Authors:  Kirk T Kitchin; Judy A Richards; Brian L Robinette; Kathleen A Wallace; Najwa H Coates; Benjamin T Castellon; Eric A Grulke
Journal:  Cell Biol Toxicol       Date:  2022-07-25       Impact factor: 6.819

2.  Effect of DL-penicillamine on the aorta of growing chickens. Ultrastructural and biochemical studies.

Authors:  I Pasquali Ronchetti; C Fornieri; M Baccarani Contri; D Quaglino; E Caselgrandi
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

3.  Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Authors:  Nadiya Druzhyna; Bartosz Szczesny; Gabor Olah; Katalin Módis; Antonia Asimakopoulou; Athanasia Pavlidou; Petra Szoleczky; Domokos Gerö; Kazunori Yanagi; Gabor Törö; Isabel López-García; Vassilios Myrianthopoulos; Emmanuel Mikros; John R Zatarain; Celia Chao; Andreas Papapetropoulos; Mark R Hellmich; Csaba Szabo
Journal:  Pharmacol Res       Date:  2016-08-10       Impact factor: 7.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.